The “Cytokine Storm” and Inflammatory Response to SARS-CoV-2

SARS-CoV-2 infection in patients has shown increased secretion of IL-1β, IFN-γ, IP-10/CXCL10, MCP-1/CCL2, IL-4, and IL-10. In addition, the infection has shown elevated levels of inflammatory cytokines such as IL-2, IL-6, IL-7, IL-10, G-CSF, IP-10/CXCL10, MCP-1/CCL2, MIP-1A, and TNF-α generating possible “cytokine storm”1,2. The treatment of cytokine storm has become increasingly important in helping coronavirus patients. Studies have shown that the IL-6R (Interleukin-6 Receptor) plays an important role in alleviating Cytokine Release Syndrome (CRS)2. While causes for inflammatory responses remain widely unknown, Leinco can assist researchers in providing many of these cytokines.

SARS-CoV-2 Increased Secretion & Inflammation of CytokinesSARS-CoV-2 Cytokine Response

Cytokines

- -
- -
Product
Clone
Applications
Prod No.
Package Size
I-217
100 µg
ELISA Cap
FC
I-835
10 µg
I-211
100 µg
25 µg
5 µg
I-1180
1.0 mg
10 µg
100 µg
500 µg
I-219
10 µg
50 µg
500 µg
ELISA Cap
FC
I-843
10 µg
I-533
25 µg
ELISA
FC
WB
I-1191
10 µg
50 µg
500 µg
I-205
10 µg
25 µg
5 µg
ELISA Cap
FC
I-837
20 µg
12346

Antibodies to Cytokines

Additional conjugates available for each. 

- -
- -
Product
Clone
Applications
Prod No.
Package Size
IHC
N
WB
M142
100 µg
25 µg
14215
ELISA
N
C1447
100 µg
25 µg
500 µg
93321
ELISA Indirect
IHC FFPE
N
WB
C1390
100 µg
25 µg
500 µg
123616
N
C1427
100 µg
25 µg
500 µg
134013
ELISA Cap
N
WB
C1423
100 µg
25 µg
500 µg
IHC FF
N
WB
I-236
100 µg
25 µg
67604
ELISA Cap
N
WB
G669
100 µg
25 µg
500 µg
ELISA Indirect
N
WB
G134
100 µg
25 µg
N
WB
G119
100 µg
25 µg
MP1-22E9
in vivo
N
WB
G670
1.0 mg
100 mg
25 mg
5.0 mg
50 mg
12348

ELISA Development Kits

- -
- -
Product
Clone
Applications
Prod No.
Package Size
ELISA
H255
25 µg
250 µg
5 µg
123
  1. Y. Fu, et al. 2020, Virologica Sinica, 35:266–271
  2. C. Zhang, et al. 2020, International Journal of Antimicrobial Agents, 105954
  3. Image: G. Schett, et al. 2020, Nat Rev Immunol20, 271–272.